Use Of Daptomycin In Critically Ill Children With Bloodstream Infections And Complicated Skin And Soft-Tissue Infections

We report our clinical experience with the use of daptomycin, administered in the dosage of 8mg/kg/d in 3 minutes, in treating 12 critically ill children younger than 12 years, with bloodstream infections (n = 9) and complicated skin and soft-tissue infections (n = 3). Mean treatment duration was 14 +/- 5 days; microbiologic eradication was achieved in all patients, and no drug related adverse events occurred.